24 Apr How Metabolism Is Changing the Way Scientists Understand Cancer
Cancer research is entering a new phase. For years, scientists focused on how cancer cells grow and divide. That model still matters, but it is no longer enough. New research shows something deeper: cancer cells are not fixed. They can change their identity and shift how they behave based on internal signals.
One of the strongest of those signals is metabolism. Emerging research shows that metabolism does more than provide energy — it also controls how genes are turned on and off, which means it can shape what a cancer cell becomes. This is a major shift in thinking, and it changes how researchers approach treatment and discovery.
The Core Discovery: A Metabolic–Epigenetic Link
What Scientists Found
Researchers identified a key interaction between two molecules: PKM2, a metabolic enzyme, and EZH2, an epigenetic regulator. These two work together inside cancer cells, forming a complex that shuts down specific genes. One of the genes affected controls how cells process fatty acids. When this PKM2-EZH2 system is active, cancer cells rely heavily on glycolysis — a fast way to generate energy.
What Happens When the System Breaks
When PKM2 activity is reduced, cells shift their metabolism away from glycolysis and begin using fatty acid oxidation instead. This shift does more than change energy use — it changes gene expression. A molecule called acetyl-carnitine increases, helping add chemical marks to DNA-associated proteins that activate certain genes. One key gene is GATA3, which controls cell identity. When GATA3 is activated, cancer cells shift toward a more mature, less aggressive state. This is a direct link between metabolism and identity.
Why This Matters for Breast Cancer
The Challenge of TNBC
Triple negative breast cancer (TNBC) is one of the hardest cancers to treat. It lacks the common targets used in other breast cancer therapies, which limits treatment options and leads to poorer outcomes. Scientists have been searching for new approaches to this problem.
A New Strategy: Change the Cell, Not Just Kill It
This research suggests a new idea. Instead of only trying to destroy cancer cells, scientists can try to change them. By shifting metabolism, they can push cells into a different state that may respond better to treatment. In this case, cells move toward a luminal identity — and luminal breast cancers have more treatment options and better outcomes. This is a strategic shift that focuses on control, not just elimination.
The Role of Combination Therapy
Why One Treatment Is Not Enough
Cancer cells adapt quickly. If one pathway is blocked, they find another. This study tested a combined approach: blocking the EZH2 pathway alongside blocking fatty acid oxidation. The result was clear — tumor growth decreased significantly when both were used together, while single treatments did not produce the same effect.
What This Means Going Forward
Combination therapy is becoming more important because it targets multiple weaknesses at once, reducing the chance that cancer cells will adapt and survive. It also reflects a more realistic view of cancer: these cells are flexible, and treatments must match that flexibility.
How This Changes Research Thinking
Old models treated metabolism as a support system that provided energy for growth. New models treat it as a control system that influences gene expression and cell identity. Researchers describe the shift vividly — when one enzyme was adjusted, a complete and immediate shift in cell behavior followed, not a gradual one. Researchers like Chun Ju Chang have emphasized the importance of careful, step-by-step data review in understanding what these complex systems truly show.
Challenges That Remain
Cancer Cells Are Highly Adaptive
Cancer cells can change pathways quickly. If one metabolic route is blocked, another may take over, which means treatments must stay ahead of these changes.
Balancing Effectiveness and Safety
Many metabolic pathways are also used by healthy cells, meaning targeting them can cause side effects. Researchers must find ways to target cancer cells more selectively.
Understanding Individual Differences
Not all tumors behave the same — genetic mutations often affect metabolism. Personalized and stratified treatment strategies need to be developed to account for this variation.
Actionable Takeaways for Research and Practice
For scientists, the key priorities are studying metabolism and gene regulation together, using combination therapies in experimental design, and tracking how cells adapt over time. For institutions, this means supporting interdisciplinary research teams, investing in tools that measure both metabolism and epigenetics, and encouraging collaboration across specialties. For students and early researchers, building skills in both molecular biology and metabolic science — alongside strong data interpretation habits — will be essential.
The Future of Cancer Research
Cancer research is moving toward integrated models where metabolism, gene regulation, and cell identity are studied as connected networks rather than isolated systems. The goal is not just to kill cancer cells — it is to control them, reshape them, and make them easier to treat. Understanding these connections will drive the next generation of discoveries in oncology.
Disclaimer: The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Some links are sponsored. Products, services and providers are not warranted or endorsed by MedicalResearch.com or Eminent Domains Inc. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.
Last Updated on April 24, 2026 by Marie Benz MD FAAD